PATENT CLAIM ANALYSIS

Application Number: 15753671
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "186100"]

Abstract:
The present invention relates to compositions and methods for the treatment and prevention of canine influenza virus (CIV) and CIV-related pathology. The present invention is based in part upon the discovery that various mutations in segment 1 and segment 2 of the CIV genome, thereby encoding mutant PB2 and PB1 protein, render the virus to be temperature-sensitive.

Claim (Index 12):
The composition of  claim 1 , wherein the LACIV comprises\n one or more mutations in segment 1, which encodes mutant PB2; and one or more mutations in segment 2, which encodes mutant PB1.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 88.0
- Lexical Diversity: 1.4
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15753688', '12254131', '15568836', '14038704', '12381550']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7530163268189687
- 35 USC 102 Novelty (BERT): 0.5946723164268745
- Combined Prediction Score: 0.7371819257797593
- Mean Citation Score: 455.5842
- Max Citation Score: 593.8792
- Similarity Product: 399.92610262160304

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test